4.3 Article

Diagnosis and Management of Acute Aortic Syndromes: Dissection, Intramural Hematoma, and Penetrating Aortic Ulcer

Journal

CURRENT CARDIOLOGY REPORTS
Volume 16, Issue 10, Pages -

Publisher

SPRINGER
DOI: 10.1007/s11886-014-0536-x

Keywords

Acute aortic syndrome; Intramural hematoma; Penetrating aortic ulcer; Aortic dissection

Funding

  1. Abbott
  2. Amgen
  3. AstraZeneca
  4. Beckman Coulter
  5. BG Medicine
  6. BRAHMS
  7. Bristol-Myers Squibb
  8. Buhlmann
  9. Critical Diagnostics
  10. CV Therapeutics
  11. Daiichi Sankyo Co Ltd
  12. Eli Lilly and Co
  13. GlaxoSmithKline
  14. Genzyme
  15. Merck and Co
  16. Intarcia
  17. Merck
  18. Nanosphere
  19. Novartis Pharmaceuticals
  20. Ortho-Clinical Diagnostics
  21. Pfizer
  22. Randox
  23. Roche Diagnostics
  24. Sanofi-Aventis
  25. Siemens
  26. Singulex
  27. Takeda

Ask authors/readers for more resources

Acute aortic syndromes constitute a spectrum of conditions characterized by disruptions in the integrity of the aortic wall that may lead to potentially catastrophic outcomes. They include classic aortic dissection, intramural hematoma, and penetrating aortic ulcer. Although imaging studies are sensitive and specific, timely diagnosis can be delayed because of variability in presenting symptoms and the relatively low frequency with which acute aortic syndromes are seen in the emergency setting. Traditional classification systems, such as the Stanford system, facilitate early treatment decision-making through recognition of the high risk of death and major complications associated with involvement of the ascending aorta (type A). These patients are treated surgically unless intractable and severe co-morbidities are present. Outcomes with dissections that do not involve the ascending aorta (type B) depend on the presence of acute complications (e.g., malperfusion, early aneurysm formation, leakage), the patency and size of the false lumen, and patient co-morbidities. Patients with uncomplicated type B dissections are initially treated medically. Endovascular techniques have emerged as an alternative to surgery for the management of complicated type B dissections when intervention is necessary. Patients with acute aortic syndromes require aggressive medical care, risk stratification for additional complications and targeted genetic assessment as well as careful long-term monitoring to assess for evolving complications. The optimal care of patients with acute aortic syndrome requires the cooperation of members of an experienced multidisciplinary team both in the acute and chronic

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available